Marles Geist
Adult Health · Chehalis, WANPI 1073759486
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,070 of the $1,559 with a category attached, or 68.7%. It is spread thinly across 19 manufacturers, the largest accounting for just 23.0%. Reporting peaked in 2022 at $638 and has fallen 78.4% since, to $138 in 2025.
Across 51 payments — averaging $30.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$358
- Novartis$326
- AstraZeneca$179
- Sanofi-aventis U.S. LLC$100
- Sanofi$99
- AbbVie$89
- plus $408 from 13 others
What the payments were for
- Food & beverage$1,07069%
- Education$18912%
- Other$29919%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 13 | $358 |
| Novartis | 6 | $326 |
| AstraZeneca | 4 | $179 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Sanofi | 3 | $99 |
| AbbVie | 4 | $89 |
| Eisai Inc. | 3 | $64 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $58 |
| Bristol Myers Squibb | 2 | $54 |
| Lilly USA, LLC | 2 | $45 |
| Astellas Pharma US Inc | 2 | $29 |
| Seagen Inc. | 1 | $28 |
| CTI Biopharma Corp. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $23 |
| Morphosys, US Inc. | 1 | $18 |
| Blueprint Medicines Corporation | 1 | $14 |
| Rigel Pharmaceuticals, Inc. | 1 | $13 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,559 in reported general payments places this provider in the 80th percentile of 252 adult health providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 14 | $307 |
Paid to pharmacies, not to this prescriber.
Other adult health in Chehalis
- George BaxterSeattle$868K
- April WatkinsSeattle$101K
- Ming Chi HsiaoTacoma$46K
- Leslie SwansonSeattle$18K
- Kindra Clark-SnustadSeattle$10K
- Amanda NortonBellevue$8K
- Alexxia RichmondSnohomish$7K
- Jonathan TurowskiMill Creek$7K
- Tyler ChristensenWalla Walla$6K
- Robert PleyoRichland$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.